HOME >> BIOLOGY >> NEWS
Preeclampsia, fetal development problems may be linked to low levels of hormone

CHAPEL HILL -- New research from the University of North Carolina at Chapel Hill ties low levels of a hormone secreted by the uterus and embryos to problems with pregnancy and fetal development.

The findings also suggest that the hormone, adrenomedullin, plays a key role in maternal susceptibility to preeclampsia, a serious pregnancy complication that occurs in the third trimester. Preeclampsia affects roughly one in fifteen pregnant women and is the leading cause of death among expectant mothers.

The UNC researchers demonstrated that pregnant mice with low adrenomedullin levels had reduced litter sizes, and while embryos implanted normally in the uterus, their spacing was overcrowded and resulted in poor growth. Because the low hormone levels were caused by a genetic mutation affecting adrenomedullin production, similar genetic changes could be linked to problems in human pregnancy, the researchers said.

"Our study provides the first genetic evidence to suggest that a modest reduction in human adrenomedullin expression during pregnancy may cause profound defects during pregnancy," said Dr. Kathleen M. Caron, senior study author and an assistant professor in the departments of cell and molecular physiology and genetics at the UNC School of Medicine.

Among the potential problems are poor implantation of the embryo, failure of the placenta to establish blood flow between mother and fetus and restricted fetal growth, Caron said. "The clinical implications are that women who have mutations in the gene responsible for expressing adrenomedullin might have greater susceptibility to these pregnancy problems, including preeclampsia."

The study was published online Sept. 14 in the Journal of Clinical Investigation and will appear in the Oct. 2 print edition.

Discovered in 1993, adrenomedullin is a powerful blood vessel dilator that is essential for life. Secreted by cells throughout the body, it is involved in m
'"/>

Contact: L. H. Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine
18-Sep-2006


Page: 1 2 3

Related biology news :

1. Inflammation may cause preterm labor and fetal deaths
2. U-M team identifies gene that regulates blood-forming fetal stem cells
3. Common environmental chemicals in diet affect fetal ovarian development
4. Pregnant moms exposure to flu vaccine kick-starts fetal immune system
5. Endogenous cannabinoids linked to fetal brain damage imposed by maternal cannabis use
6. Cholesterol could be key to treating fetal alcohol syndrome
7. Eye movement tasks can be used to assess fetal alcohol spectrum disorders
8. Epilepsy drug poses high risk for fetal death and birth defects
9. Early fetal gender test demands rapid ethical policymaking
10. New procedure safer for detecting fetal anemia
11. Major findings on fetal research to be unveiled at University of Leicester

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... , ... October 04, 2019 , ... ... will be held November 10 at the Grand Elysée Hamburg Rothenbaumchaussee in Hamburg. ... Europe again this November,” said Miao Guo, Vice President of Operations and spokesperson ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... of chemicals, reagents, and medias and to be a more environmentally sustainable evolution ... culmination of years of experience and feedback from the original version we launched ...
(Date:10/3/2019)... ... 02, 2019 , ... Connecticut Innovations (CI), Connecticut’s strategic venture ... innovative, growing companies, today announced that it has closed on a $750,000 investment ... the 2018 VentureClash competition. , The outlay is part of ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., ... announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. ... facility demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... focused on the development of therapies to treat central nervous system (CNS) ...
(Date:9/17/2019)... ... 2019 , ... Catalent, a global leader in clinical supply ... Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in ... Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical ...
(Date:9/17/2019)... (PRWEB) , ... September 16, 2019 , ... ... Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings for ... Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to ...
Breaking Biology Technology:
Cached News: